Clinical profiles, treatment adherence, and quality of life in patients with severe mental disorders treated with cyamemazine: A real-world observational study
The study highlights the need for personalized treatment strategies that weigh the benefits of cyamemazine against its potential risks. Integrating pharmacological and non-pharmacological interventions could enhance patient outcomes.
Authors
- Jean‐François Obadia (ORCID: https://orcid.org/0000-0003-1644-9542)
- Michel Cermolacce
- Christelle Andrieu-Haller
- Antoine Lefrere A (ORCID: https://orcid.org/0000-0002-9678-5062)
- Guillaume B. Fond (ORCID: https://orcid.org/0000-0003-3249-2030)
- Théo Korchia (ORCID: https://orcid.org/0000-0002-6392-9322)
- Vincent Achour
- Mélanie Faugère (ORCID: https://orcid.org/0000-0001-5567-8650)
- Éloïse Maakaron (ORCID: https://orcid.org/0000-0003-2590-2927)
- Christophe Lançon (ORCID: https://orcid.org/0000-0002-0661-5781)
- Pierre Verney
Institutions
- Aix-Marseille Université (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
Publication Details
- Journal
- L Encéphale
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1016/j.encep.2025.01.003
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00